A detailed history of Revisor Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Revisor Wealth Management LLC holds 7,029 shares of ABBV stock, worth $1.18 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
7,029
Previous 2,369 196.71%
Holding current value
$1.18 Million
Previous $367 Million 222.4%
% of portfolio
0.54%
Previous 0.42%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $744,761 - $848,586
4,660 Added 196.71%
7,029 $1.18 Billion
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $151,635 - $170,776
-1,102 Reduced 31.75%
2,369 $367 Million
Q3 2023

Nov 16, 2023

BUY
$133.59 - $154.65 $463,690 - $536,790
3,471 New
3,471 $517 Million
Q2 2023

Nov 20, 2023

SELL
$132.51 - $164.9 $7,420 - $9,234
-56 Reduced 2.05%
2,681 $361 Million
Q1 2023

Nov 20, 2023

SELL
$144.61 - $166.54 $106,143 - $122,240
-734 Reduced 21.15%
2,737 $436 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Revisor Wealth Management LLC Portfolio

Follow Revisor Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Revisor Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Revisor Wealth Management LLC with notifications on news.